Le Lézard
Classified in: Health, Science and technology, Business
Subject: ERN

GBT Reports Second Quarter 2018 Results


MONTEVIDEO, Uruguay, Aug. 14, 2018 /PRNewswire/ -- Biotoscana Investments S.A. (B3: GBIO33), a biopharmaceutical group that operates in Latin America, announced today its results for the 2Q18.

 

HIGHLIGHTS

Gross revenues for 2Q18 grew 33% in constant currency, marking BRL 981M LTM.

Net revenues for 2Q18 increased by 42% in constant currency, marking BRL 882M LTM.

Gross profit up 39% in 2Q18, in constant currency. Gross margin of 53% in line with prior quarters.

Adjusted EBITDA increased by 65% in constant currency vs. 2Q17.  Adjusted EBITDA margin came to 25% in 2Q18, improving 381 bps vs. 2Q17, marking BRL 226M LTM compared to BRL 203M in 2Q17 LTM.

Net income totaled BRL 20M in 2Q18, from a loss of BRL 3M in 2Q17. Adjusted net income up 380% from 2Q17, reaching BRL 32M in 2Q18.

Lenvima launching ahead of schedule and improving clinical profile with new indications submitted. Cresemba and Zevtera approved in Peru.

Extended partnership with Gilead into the Andean region, with revenues stream in 2Q18.

 

Contacts:
Melissa Angelini
[email protected] 
+55-11-5090-5927

SOURCE Grupo Biotoscana


These press releases may also interest you

at 16:40
Pfizer Inc. today announced that its board of directors declared a $0.42 second-quarter 2024 dividend on the company's common stock, payable June 14, 2024, to holders of the Common Stock of record at the close of business on May 10, 2024. The...

at 16:40
Woodward, Inc. today announced that its Board of Directors declared a cash dividend of $0.25 per share for the quarter, payable on June 05, 2024, for stockholders of record as of May 22, 2024. About Woodward, Inc. Woodward is the global leader in...

at 16:35
Ecolab will host a live webcast of its annual meeting of stockholders. As indicated in our proxy statement, the 2024 Annual Meeting of Stockholders will be a virtual-only meeting. Details for the public webcast are as follows: TIME:...

at 16:35
Riskified Ltd. , a leader in ecommerce fraud and risk intelligence, today announced it will release its first quarter 2024 financial results before the market opens on May 15, 2024. On that day management will host a conference call and webcast at...

at 16:35
Summit Therapeutics Inc. ("Summit," "we," or the "Company") will host an earnings call to announce its first quarter 2024 financial results and provide an operational update for the Company on Wednesday, May 1, 2024, before the market opens....

at 16:33
ACTS LAW's Doug Rochen currently represents more than 1,000 men and women who have been subjected to sexual abuse, sexual assault and sexual harassment while incarcerated in jails and prisons throughout California. Recently, the Federal Correctional...



News published on and distributed by: